BackBonus Biogroup Overview

Bonus Biogroup Total Assets

Track Bonus Biogroup's total assets ($14M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$14.16M
↓ 18.31% YoYΔ $-3.17M vs prior year quarter

Peer trimmed avg / median

Loading

Bonus Biogroup Total Assets History

Loading

Bonus Biogroup vs. peers: Total Assets Comparison

Loading

Bonus Biogroup Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Bonus Biogroup (BBIXF) FAQ

As of the most recent data (June 2026), BBIXF shows a total assets of $14M. That compares with $17M in the prior-year period — down 18.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BBIXF's total assets is now $14M (was $17M) — a 18.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bonus Biogroup is outperforming or lagging.

Tracking BBIXF's total assets over time shows whether Bonus Biogroup is scaling, shrinking, or reshaping that part of the business. The current reading is $14M That compares with $17M in the prior-year period — down 18.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Bonus Biogroup's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $14M) with ownership activity and broader fundamentals.

Bonus Biogroup's total assets is $14M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.